Literature DB >> 31811708

Roles of Postdiagnosis Accumulation of Morbidities and Lifestyle Changes in Excess Total and Cause-Specific Mortality Risk in Rheumatoid Arthritis.

Kazuki Yoshida1, Tzu-Chieh Lin2, Melissa Y Wei3, Susan Malspeis2, Su H Chu1, Carlos A Camargo4, Benjamin A Raby5, Hyon K Choi6, Sara K Tedeschi1, Medha Barbhaiya7, Bing Lu1, Karen H Costenbader1, Elizabeth W Karlson1, Jeffrey A Sparks1.   

Abstract

OBJECTIVE: To elucidate how postdiagnosis multimorbidity and lifestyle changes contribute to the excess mortality of rheumatoid arthritis (RA).
METHODS: We performed a matched cohort study among women in the Nurses' Health Study (1976-2018). We identified women with incident RA and matched each by age and year to 10 non-RA comparators at the RA diagnosis index date. Specific causes of death were ascertained via death certificates and medical record review. Lifestyle and morbidity factors were reported biennially; 61 chronic conditions were combined into the Multimorbidity Weighted Index (MWI). After adjusting for baseline confounders, we used inverse probability weighting analysis to examine the mediating influence of postindex MWI scores and lifestyle factors on total, cardiovascular, and respiratory mortality, comparing women with RA to their matched comparators.
RESULTS: We identified 1,007 patients with incident RA and matched them to 10,070 non-RA comparators. After adjusting for preindex confounders, we found that hazard ratios (HRs) and 95% confidence intervals (95% CIs) were higher for total mortality (HR 1.46 [95% CI 1.32, 1.62]), as well as cardiovascular (HR 1.54 [95% CI 1.22, 1.94]) and respiratory (HR 2.75 [95% CI 2.05, 3.71]) mortality in patients with RA compared to non-RA comparators. Adjusting for postindex lifestyle factors (physical activity, body mass index, diet, smoking) attenuated but did not substantially account for this excess RA mortality. After additional adjustment for postindex MWI scores, patients with RA had HRs of 1.18 (95% CI 1.05, 1.32) for total, 1.19 (95% CI 0.94, 1.51) for cardiovascular, and 1.93 (95% CI 1.42, 2.62) for respiratory mortality.
CONCLUSION: We found that MWI scores substantially accounted for the excess total and cardiovascular mortality among women with RA. This finding underscores the importance of monitoring for the total disease burden as a whole in monitoring patients with RA.
© 2019, American College of Rheumatology.

Entities:  

Mesh:

Year:  2021        PMID: 31811708      PMCID: PMC7275877          DOI: 10.1002/acr.24120

Source DB:  PubMed          Journal:  Arthritis Care Res (Hoboken)        ISSN: 2151-464X            Impact factor:   4.794


  47 in total

1.  Rheumatoid Arthritis and Mortality Among Women During 36 Years of Prospective Follow-Up: Results From the Nurses' Health Study.

Authors:  Jeffrey A Sparks; Shun-Chiao Chang; Katherine P Liao; Bing Lu; Alexander R Fine; Daniel H Solomon; Karen H Costenbader; Elizabeth W Karlson
Journal:  Arthritis Care Res (Hoboken)       Date:  2016-06       Impact factor: 4.794

2.  Multimorbidity, Mortality, and Long-Term Physical Functioning in 3 Prospective Cohorts of Community-Dwelling Adults.

Authors:  Melissa Y Wei; Kenneth J Mukamal
Journal:  Am J Epidemiol       Date:  2018-01-01       Impact factor: 4.897

3.  Treatment Patterns of Multimorbid Patients with Rheumatoid Arthritis: Results from an International Cross-sectional Study.

Authors:  Helga Radner; Kazuki Yoshida; Ihsane Hmamouchi; Maxime Dougados; Josef S Smolen; Daniel H Solomon
Journal:  J Rheumatol       Date:  2015-06-01       Impact factor: 4.666

4.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

5.  The epidemiology of rheumatoid arthritis in Rochester, Minnesota, 1955-1985.

Authors:  S E Gabriel; C S Crowson; W M O'Fallon
Journal:  Arthritis Rheum       Date:  1999-03

6.  Mortality in rheumatoid arthritis: have we made an impact in 4 decades?

Authors:  S E Gabriel; C S Crowson; W M O'Fallon
Journal:  J Rheumatol       Date:  1999-12       Impact factor: 4.666

7.  Being overweight or obese and risk of developing rheumatoid arthritis among women: a prospective cohort study.

Authors:  Bing Lu; Linda T Hiraki; Jeffrey A Sparks; Susan Malspeis; Chia-Yen Chen; J Adebukola Awosogba; Elizabeth V Arkema; Karen H Costenbader; Elizabeth W Karlson
Journal:  Ann Rheum Dis       Date:  2014-07-23       Impact factor: 19.103

8.  Statin use in rheumatoid arthritis in relation to actual cardiovascular risk: evidence for substantial undertreatment of lipid-associated cardiovascular risk?

Authors:  Tracey E Toms; Vasileios F Panoulas; Karen M J Douglas; Helen Griffiths; Naveed Sattar; Jaqueline P Smith; Deborah P M Symmons; Peter Nightingale; George S Metsios; George D Kitas
Journal:  Ann Rheum Dis       Date:  2009-10-23       Impact factor: 19.103

Review 9.  Body mass index and the risk of rheumatoid arthritis: a systematic review and dose-response meta-analysis.

Authors:  Baodong Qin; Min Yang; Haitao Fu; Ning Ma; Tingting Wei; Qingqin Tang; Zhide Hu; Yan Liang; Zaixing Yang; Renqian Zhong
Journal:  Arthritis Res Ther       Date:  2015-03-29       Impact factor: 5.156

10.  Incidence and predictors of dyspnea on exertion in a prospective cohort of patients with rheumatoid arthritis.

Authors:  Jeffrey A Sparks; Tracy J Doyle; Xintong He; Beatrice Pan; Christine Iannaccone; Michelle L Frits; Paul F Dellaripa; Ivan O Rosas; Bing Lu; Michael E Weinblatt; Nancy A Shadick; Elizabeth W Karlson
Journal:  ACR Open Rheumatol       Date:  2019-03-15
View more
  14 in total

1.  Rheumatoid arthritis-related lung disease detected on clinical chest computed tomography imaging: Prevalence, risk factors, and impact on mortality.

Authors:  Sicong Huang; Tracy J Doyle; Mark M Hammer; Suzanne C Byrne; Weixing Huang; Allison A Marshall; Christine K Iannaccone; Jie Huang; Vivi Feathers; Michael E Weinblatt; Paul F Dellaripa; Nancy A Shadick; Jeffrey A Sparks
Journal:  Semin Arthritis Rheum       Date:  2020-09-28       Impact factor: 5.532

2.  Rheumatoid arthritis-associated interstitial lung disease: Current update on prevalence, risk factors, and pharmacologic treatment.

Authors:  Sicong Huang; Vanessa L Kronzer; Paul F Dellaripa; Kevin D Deane; Marcy B Bolster; Vivek Nagaraja; Dinesh Khanna; Tracy J Doyle; Jeffrey A Sparks
Journal:  Curr Treatm Opt Rheumatol       Date:  2020-09-01

3.  Multimorbidity Burden in Rheumatoid Arthritis: A Population-based Cohort Study.

Authors:  Tina M Gunderson; Elena Myasoedova; John M Davis; Cynthia S Crowson
Journal:  J Rheumatol       Date:  2021-02-15       Impact factor: 5.346

4.  Mortality is increased in patients with rheumatoid arthritis or diabetes compared to the general population - the Nord-Trøndelag Health Study.

Authors:  Ingrid Sæther Houge; Mari Hoff; Ranjeny Thomas; Vibeke Videm
Journal:  Sci Rep       Date:  2020-02-27       Impact factor: 4.379

5.  Epidemiology of rheumatoid arthritis in sub-Saharan Africa: a systematic review and meta-analysis protocol.

Authors:  Mickael Essouma; Jan René Nkeck; Francky Teddy Endomba; Jean Joel Bigna; Stéphane Ralandison
Journal:  Syst Rev       Date:  2020-04-17

6.  Patterns of multimorbidity and their effects on adverse outcomes in rheumatoid arthritis: a study of 5658 UK Biobank participants.

Authors:  Frances S Mair; Stefan Siebert; Ross McQueenie; Barbara I Nicholl; Bhautesh D Jani; Jordan Canning; Sara Macdonald; Colin McCowan; Joanne Neary; Susan Browne
Journal:  BMJ Open       Date:  2020-11-23       Impact factor: 2.692

7.  Depression and Subsequent Risk for Incident Rheumatoid Arthritis Among Women.

Authors:  Jeffrey A Sparks; Susan Malspeis; Jill Hahn; Jiaqi Wang; Andrea L Roberts; Laura D Kubzansky; Karen H Costenbader
Journal:  Arthritis Care Res (Hoboken)       Date:  2021-01       Impact factor: 4.794

Review 8.  Testing the Effects of Disease-Modifying Antirheumatic Drugs on Vascular Inflammation in Rheumatoid Arthritis: Rationale and Design of the TARGET Trial.

Authors:  Jon T Giles; Pamela M Rist; Katherine P Liao; Ahmed Tawakol; Zahi A Fayad; Venkatesh Mani; Nina P Paynter; Paul M Ridker; Robert J Glynn; Fengxin Lu; Rachel Broderick; Meredith Murray; Kathleen M M Vanni; Daniel H Solomon; Joan M Bathon
Journal:  ACR Open Rheumatol       Date:  2021-05-01

9.  Influence of Multimorbidity on New Treatment Initiation and Achieving Target Disease Activity Thresholds in Active Rheumatoid Arthritis: A Cohort Study Using the Rheumatology Informatics System for Effectiveness Registry.

Authors:  Bryant R England; Huifeng Yun; Lang Chen; Jared Vanderbleek; Kaleb Michaud; Ted R Mikuls; Jeffrey R Curtis
Journal:  Arthritis Care Res (Hoboken)       Date:  2021-08-02       Impact factor: 5.178

10.  Incident arterial vascular events in a cohort of Puerto Ricans with rheumatoid arthritis.

Authors:  Ariana González-Meléndez; Ruth M Fred-Jiménez; Mariangelí Arroyo-Ávila; Leyda Díaz-Correa; Naydi Pérez-Ríos; Noelia Rodríguez; Grissel Ríos; Luis M Vilá
Journal:  SAGE Open Med       Date:  2020-09-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.